Strategic Partnerships Genomind actively pursues collaborations with diagnostic labs and healthcare providers (Evexia Diagnostics partnership; SQP ACO; Epic integrations; Parkview Physicians Group) which creates co-selling opportunities for pharmacogenetic testing, population health management, and integrated EHR workflows.

Direct to Consumer Expansion Genomind offers a direct-to-consumer Mental Health Map test, presenting a potential revenue channel and consumer-facing upsell for personalized wellness products, as well as a pathway to engage patients who are exploring genetic insights outside clinician orders.

Clinical Workflow Integration Existing integrations with Epic and laboratory ordering/results systems indicate a strong value proposition for health systems and large clinics seeking seamless pharmacogenetic testing within established clinical workflows, reducing friction for scale.

Clinical Expertise Platform With access to PhD and PharmD expert consultations and a suite of precision health tools, Genomind can partner to monetize decision-support capabilities, care management programs, and provider education bundles for pharmacogenomics and personalized medicine.

Growth through Health Networks Active partnerships with regional healthcare organizations and Accountable Care Organizations, plus a mid-size employee base and significant revenue, position Genomind to expand into population health contracts, value-based care pilots, and multi-site hospital collaborations.